The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug ...

Submission of New Drug Application for Paltusotine for the Treatment of AcromegalyCompleted Upsized Public Offering of $575M of Common Stock ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...

Announced that it has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) seeking ...

This drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related macular degeneration (nAMD). The US FDA has cleared an investigational new ...

Through a collaboration with the National Institutes of Health, Trevena is also exploring TRV045 as a potential treatment for epilepsy. S1P receptors are located throughout the body, including the ...

and information on how to submit an investigational new drug (IND) application to administer an investigational product to humans. The staff of CAB and MATTB comprises consumer safety officers ...

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...

Recent positive Type C meeting with the U.S. Food and Drug Administration (FDA) confirmed ELPIS II is pivotal and, if positive, acceptable for Biological License Application (BLA) submission for full ...

In July, the FDA cleared CGEN’s investigational new drug (IND) application seeking to initiate ... Compugen has a mixed earnings surprise history. The company’s earnings beat estimates in ...